SE341239B - - Google Patents

Info

Publication number
SE341239B
SE341239B SE1229767A SE1229767A SE341239B SE 341239 B SE341239 B SE 341239B SE 1229767 A SE1229767 A SE 1229767A SE 1229767 A SE1229767 A SE 1229767A SE 341239 B SE341239 B SE 341239B
Authority
SE
Sweden
Application number
SE1229767A
Inventor
H Bennich
S Johansson
L Wide
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE1229767A priority Critical patent/SE341239B/xx
Priority to FR1588874D priority patent/FR1588874A/fr
Priority to DK418468A priority patent/DK131400B/da
Priority to CH1313868A priority patent/CH534878A/de
Priority to CH115071A priority patent/CH551009A/de
Priority to CH115171A priority patent/CH551010A/xx
Priority to BE720341D priority patent/BE720341A/xx
Priority to GB345771A priority patent/GB1248765A/en
Priority to DE19681798417 priority patent/DE1798417A1/de
Priority to GB4180168A priority patent/GB1248764A/en
Priority to DE19681798418 priority patent/DE1798418A1/de
Priority to DE19681798170 priority patent/DE1798170C2/de
Priority to NL6812559A priority patent/NL162209C/nl
Priority to NO345868A priority patent/NO127685B/no
Priority to FI249868A priority patent/FI48785C/fi
Priority to AT873168A priority patent/AT288593B/de
Priority to JP6421968A priority patent/JPS50892B1/ja
Priority to CS626568A priority patent/CS191857B2/cs
Priority to AT359370A priority patent/AT295744B/de
Priority to ES357863A priority patent/ES357863A1/es
Priority to DK364770A priority patent/DK132970C/da
Priority to DK364870A priority patent/DK133205C/da
Publication of SE341239B publication Critical patent/SE341239B/xx
Priority to CA130948A priority patent/CA937142A/en
Priority to NO247772A priority patent/NO138182C/no
Priority to FI300973A priority patent/FI55409C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1015—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1078—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against an immunoglobulin, i.e. being an (anti)-anti-idiotypic antibody
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Botany (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SE1229767A 1967-09-06 1967-09-06 SE341239B (nl)

Priority Applications (25)

Application Number Priority Date Filing Date Title
SE1229767A SE341239B (nl) 1967-09-06 1967-09-06
FR1588874D FR1588874A (nl) 1967-09-06 1968-08-28
DK418468A DK131400B (da) 1967-09-06 1968-08-30 Fremgangsmåde til påvisning af eller bestemmelse in vitro af reagin-immunglobuliner (reagin-Ig) i en vandholdig prøve og rettet mod et givet allergen, og hjælpemiddel til anvendelse ved udøvelse af fremgangsmåden.
CH1313868A CH534878A (de) 1967-09-06 1968-09-02 Verfahren zur Bestimmung der Anwesenheit von gegen bestimmte Allergene gerichteten Reagin-Immunoglobulinen (Reagin-Ig) in wässrigen Proben
CH115071A CH551009A (de) 1967-09-06 1968-09-02 Verfahren zur herstellung markierter antikoerper gegen reagin-immunoglobuline.
CH115171A CH551010A (de) 1967-09-06 1968-09-02 Verfahren zur herstellung eines markierten reagin-immunoglobulins.
DE19681798170 DE1798170C2 (de) 1967-09-06 1968-09-03 Verfahren zur Bestimmung der Anwesenheit von gegen bestimmte Allergene gerichteten Reagin-Immunoglobulinen (Reagin-Ig) in wäßrigen Proben
GB345771A GB1248765A (en) 1967-09-06 1968-09-03 Reagin-immunoglobulins (reagin-ig) and their use
DE19681798417 DE1798417A1 (de) 1967-09-06 1968-09-03 Markierte Reagin-Immunoglobuline (Reagin-Ig)
GB4180168A GB1248764A (en) 1967-09-06 1968-09-03 Antibodies against reagin-immunoglobulins (reagin-ig), and their use
DE19681798418 DE1798418A1 (de) 1967-09-06 1968-09-03 Markierte Antikoerper gegen Reagin-Immunoglobuline
BE720341D BE720341A (nl) 1967-09-06 1968-09-03
NL6812559A NL162209C (nl) 1967-09-06 1968-09-04 Werkwijze voor het aantonen van tegen allergenen gerichte reagin-immunoglobulinen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze.
NO345868A NO127685B (nl) 1967-09-06 1968-09-05
FI249868A FI48785C (fi) 1967-09-06 1968-09-05 Menetelmä ja apuaine tiettyyn allergeeniin vaikuttavien reagiini-immun oglobuliinien (reagin-Ig) toteamiseksi vesipitoisissa näytteissä.
AT873168A AT288593B (de) 1967-09-06 1968-09-06 Verfahren zur Bestimmung von gegen bestimmte Allergene wirkenden Reagin-Immunoglobulinen (Reagin-Ig) in wässerigen Testproben
JP6421968A JPS50892B1 (nl) 1967-09-06 1968-09-06
CS626568A CS191857B2 (en) 1967-09-06 1968-09-06 Means for detecting the reagin-immunoglobulines
AT359370A AT295744B (de) 1967-09-06 1968-09-06 Verfahren zur Herstellung markierter Antikörper gegen Reagin-Immunoglobuline
ES357863A ES357863A1 (es) 1967-09-06 1969-09-05 Un metodo para determinar la presencia de reagin-inmunoglo-bulinas.
DK364770A DK132970C (da) 1967-09-06 1970-07-14 Immunkemisk reagens bestaende af eller indeholdende antistoffer der er specifikt rettet mod reagin-ig eller fragmenter deraf
DK364870A DK133205C (da) 1967-09-06 1970-07-14 Middel bestaende af eller indeholdende mindst et immunglobulin tilhorende reagin-immunglobulin-klassen og beregnet til anvendelse ved immunkemiske reaktioner in vitro i vandholdig veske
CA130948A CA937142A (en) 1967-09-06 1971-12-23 Reagin-immunoglobulins (reagin-ig) and their use
NO247772A NO138182C (no) 1967-09-06 1972-07-11 Antilegemer spesifikt rettet mot immunglobulin e (ige) eller mot fragment av ige.
FI300973A FI55409C (fi) 1967-09-06 1973-09-26 Maerkta antikroppar mot immunglobulin e

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE1229767A SE341239B (nl) 1967-09-06 1967-09-06

Publications (1)

Publication Number Publication Date
SE341239B true SE341239B (nl) 1971-12-20

Family

ID=20295495

Family Applications (1)

Application Number Title Priority Date Filing Date
SE1229767A SE341239B (nl) 1967-09-06 1967-09-06

Country Status (13)

Country Link
JP (1) JPS50892B1 (nl)
AT (2) AT288593B (nl)
BE (1) BE720341A (nl)
CH (1) CH534878A (nl)
CS (1) CS191857B2 (nl)
DK (1) DK131400B (nl)
ES (1) ES357863A1 (nl)
FI (1) FI48785C (nl)
FR (1) FR1588874A (nl)
GB (1) GB1248764A (nl)
NL (1) NL162209C (nl)
NO (2) NO127685B (nl)
SE (1) SE341239B (nl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE31006E (en) * 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) * 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
US3966897A (en) * 1973-04-02 1976-06-29 Marine Colloids, Inc. Medium for use in bioassay and method of using same
US4041146A (en) * 1975-05-01 1977-08-09 General Electric Company Method for detection of biological particles
GB1555142A (en) * 1975-08-14 1979-11-07 Sinai School Medicine Blood cell typing and compatibility test procedure
AT343822B (de) * 1976-08-20 1978-06-26 Immuno Ag Radioimmunologisches verfahren und einrichtung zur bestimmung von antigenen
US4289748A (en) * 1979-05-31 1981-09-15 United States Of America Ultrasensitive enzymatic radioimmunoassay method
FR2502786B1 (fr) * 1981-03-24 1985-06-21 Stallergenes Laboratoire Procede de fixation d'antigenes et d'anticorps sur support de polysaccharides, et utilisation du produit ainsi obtenu pour les dosages immunologiques
US4481298A (en) * 1981-04-13 1984-11-06 Amf Incorporated Pre-precipitated double antibody immunoassay method
NL8102178A (nl) * 1981-05-02 1982-12-01 Stichting Centraal Lab Werkwijze voor het aantonen van tegen bepaalde antigenen gerichte antistoffen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze.
JPS6199195U (nl) * 1984-11-30 1986-06-25

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE31006E (en) * 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other

Also Published As

Publication number Publication date
CH534878A (de) 1973-03-15
NO138182C (no) 1978-07-26
CS191857B2 (en) 1979-07-31
NL162209B (nl) 1979-11-15
DE1798170B1 (de) 1972-04-27
FI48785C (fi) 1974-12-10
FR1588874A (nl) 1970-03-16
NO138182B (no) 1978-04-10
FI48785B (nl) 1974-09-02
BE720341A (nl) 1969-02-17
DK131400C (nl) 1975-11-24
NL6812559A (nl) 1969-03-10
DK131400B (da) 1975-07-07
GB1248764A (en) 1971-10-06
NO127685B (nl) 1973-07-30
AT295744B (de) 1972-01-10
AT288593B (de) 1971-03-10
JPS50892B1 (nl) 1975-01-13
NL162209C (nl) 1980-04-15
ES357863A1 (es) 1970-04-01

Similar Documents

Publication Publication Date Title
AT298283B (nl)
DK131400C (nl)
AU2277767A (nl)
AU2977667A (nl)
AU2528767A (nl)
AU1273466A (nl)
AU2454867A (nl)
AU2256867A (nl)
AU2116667A (nl)
BE710139A (nl)
BE697821A (nl)
AU1763766A (nl)
BE711464A (nl)
BE711189A (nl)
AU1868267A (nl)
BE711120A (nl)
BE692332A (nl)
BE710371A (nl)
BE710285A (nl)
BE692374A (nl)
BE710136A (nl)
BE709619A (nl)
BE709358A (nl)
BE708758A (nl)
BE708317A (nl)